share_log

Inozyme Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Samlyn Capital, LLC(5.5%),Samlyn, LP(5.5%), etc.

SEC announcement ·  Feb 14 16:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more